New Open Data Portal Will Improve Neurofibromatosis Research
Free-Photos / Pixabay

New Open Data Portal Will Improve Neurofibromatosis Research

According to a story from EurekAlert!, a collaboration of Sage Bionetworks, The Children's Tumor Foundation (CTF), and the Neurofibromatosis Therapeutic Acceleration Program (NTAP) have announced the initiation of the very…

Continue Reading New Open Data Portal Will Improve Neurofibromatosis Research
Potential Treatment for Lupus is Granted Fast Track Designation From the FDA
frolicsomepl / Pixabay

Potential Treatment for Lupus is Granted Fast Track Designation From the FDA

According to a story from BioSpace, Incyte Corporation and Eli Lilly and Company recently announced that the US Food and Drug Administration (FDA) has given the drug baricitinib Fast Track…

Continue Reading Potential Treatment for Lupus is Granted Fast Track Designation From the FDA
Can an Intellectually Active Lifestyle Provide Benefits Against Huntington’s Disease? This Study Says Yes
omaralnahi / Pixabay

Can an Intellectually Active Lifestyle Provide Benefits Against Huntington’s Disease? This Study Says Yes

According to a story from news-medical.net, a team of researchers has found that patients who are more intellectually active can slow the neurodegeneration that appears in Huntington's disease. Such as…

Continue Reading Can an Intellectually Active Lifestyle Provide Benefits Against Huntington’s Disease? This Study Says Yes

CZI has Committed 64 Million Dollars to the Research of Neurodegenerative Disorders

Neurodegenerative disorders affect millions of people across the world. They include Amyotrophic Lateral Sclerosis, Parkinson's disease, Huntington's disease, and Alzheimer's disease, among others. For most neurodegenerative diagnoses, there are no effective treatments, no…

Continue Reading CZI has Committed 64 Million Dollars to the Research of Neurodegenerative Disorders
New Measure Developed to Assess the Severity of Charcot-Marie-Tooth Disease in Babies
1041483 / Pixabay

New Measure Developed to Assess the Severity of Charcot-Marie-Tooth Disease in Babies

According to a story from Charcot-Marie-Tooth News, a group of scientists have developed a new scale that can be used to predict disease severity in infants that are diagnosed with…

Continue Reading New Measure Developed to Assess the Severity of Charcot-Marie-Tooth Disease in Babies
Phase 1 Gene Transfer Trial for Recessive Dystrophic Epidermolysis Bullosa is Recruiting Patients
PixLoger / Pixabay

Phase 1 Gene Transfer Trial for Recessive Dystrophic Epidermolysis Bullosa is Recruiting Patients

According to a story from Debra of America, a new Phase 1 clinical trial being operated by Stanford University is currently recruiting participants. This trial will be a test of…

Continue Reading Phase 1 Gene Transfer Trial for Recessive Dystrophic Epidermolysis Bullosa is Recruiting Patients
Scientists May Have Found a New Way to Predict The Severity of Type 2A Charcot-Marie-Tooth Disease
DarkoStojanovic / Pixabay

Scientists May Have Found a New Way to Predict The Severity of Type 2A Charcot-Marie-Tooth Disease

According to a story from Charcot-Marie-Tooth news, researchers have found that models of mutations affecting the mitofusin 2 protein (MFN2), which is the protein that is affected Charcot-Marie-Tooth disease type…

Continue Reading Scientists May Have Found a New Way to Predict The Severity of Type 2A Charcot-Marie-Tooth Disease
The Vital Role of the National Amyotrophic Lateral Sclerosis (ALS) Registry
valelopardo / Pixabay

The Vital Role of the National Amyotrophic Lateral Sclerosis (ALS) Registry

According to a story from the Centers for Disease Control and Prevention, the National ALS Registry is playing a vital role in learning more about amyotrophic lateral sclerosis, a devastating…

Continue Reading The Vital Role of the National Amyotrophic Lateral Sclerosis (ALS) Registry
Chinese Researcher’s Gene Editing Project Lands Him in Hot Water, But Could it Lead to Answers for Rare Disease Patients in Future?
source: pixabay.com

Chinese Researcher’s Gene Editing Project Lands Him in Hot Water, But Could it Lead to Answers for Rare Disease Patients in Future?

One Chinese scientist has completed a research project that has shocked many in the medical community. Two twin baby girls born in November of 2018 where the recipients of his…

Continue Reading Chinese Researcher’s Gene Editing Project Lands Him in Hot Water, But Could it Lead to Answers for Rare Disease Patients in Future?
Drug Developer Receives $900,000 for the Development of a Gene Therapy for Epidermolysis Bullosa
ColiN00B / Pixabay

Drug Developer Receives $900,000 for the Development of a Gene Therapy for Epidermolysis Bullosa

According to a story from pm360online.com, the gene therapy company Fibrocell Science, Inc., recently received an investment of $900,000 from the Epidermolysis Bullosa Medical Research Foundation (EBMRF) and the EB…

Continue Reading Drug Developer Receives $900,000 for the Development of a Gene Therapy for Epidermolysis Bullosa

Clinical Trial Results With Velcade in Mantle Cell Lymphoma Inspire Continued Research

According to a story from curetoday.com, a recent Phase 2 trial has demonstrated that bortezomib (marketed as Velcade) has the potential to be an effective therapy for patients with mantle…

Continue Reading Clinical Trial Results With Velcade in Mantle Cell Lymphoma Inspire Continued Research